EUVIMEDEUVIMED entdecken
Crossref

Lianhua Qingwen granules biphasically regulate CYP3A4 and mediate metabolic drug interactions via LXRα-interfered dynamic rearrangement of PXR–HSP90α/RXRα/SRC-1 complex

Kexin Yang, Jiangping Li, Xinqian Zhao, Zuqiang Wu, Linhu Ye

Food and Chemical Toxicology · 2026

DOI: 10.1016/j.fct.2026.116357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2026. Verfasst von Kexin Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 561113, China. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Pregnane X Receptor, Liver X Receptors, Nuclear Receptor Coactivator 1. Die Arbeit nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lianhua Qingwen granules (LHQW) are widely used to treat acute respiratory infections. Their co-administration with other clinical drugs carries potential risks of metabolic drug interactions (MDIs). This study aimed to clarify the regulatory mechanism of LHQW on cytochrome P450 3A4 (CYP3A4), focusing on LXRα's impact on protein interactions among PXR, HSP90α, RXRα, and SRC-1. The results demonstrated that LHQW exerts temporal biphasic regulation on CYP3A4. A 12-h LHQW treatment promotes PXR-HSP90α binding and the dissociation of the PXR-RXRα/SRC-1 complex, downregulating CYP3A4 expression and elevating systemic exposure to atorvastatin (ATV); this effect can be further potentiated by LXRα activation. In contrast, 72-h treatment promoted PXR-HSP90α dissociation and PXR-RXRα/SRC-1 assembly, facilitating PXR nuclear translocation, upregulating CYP3A4, and accelerating ATV clearance in vivo. Notably, LXRα activation increased cytosolic PXR-HSP90α binding, which hindered PXR-RXRα/SRC-1 complex formation and the nuclear accumulation of PXR, thereby counteracting the 72-h induction of CYP3A4. This effect was abolished by LXRα silencing. These findings reveal that LHQW mediates the temporal biphasic modulation of CYP3A4 and subsequent MDIs via LXRα-driven dynamic rearrangement of the PXR-cofactor complex, providing mechanistic insights for safer polytherapy in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP3APregnane X ReceptorLiver X ReceptorsNuclear Receptor Coactivator 1Drugs, Chinese HerbalHSP90 Heat-Shock ProteinsRetinoid X Receptor alphaHumansDrug InteractionsAnimalsHep G2 Cells

Stichwörter der Autor:innen

CYP3A4LXRαLianhua Qingwen granulesMetabolic drug interactionsPXR

Substanzen

Cytochrome P-450 CYP3APregnane X ReceptorLiver X ReceptorsNuclear Receptor Coactivator 1Drugs, Chinese HerbalHSP90 Heat-Shock ProteinsRetinoid X Receptor alphaCYP3A4 protein, human

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 561113, China.
  • Department of Pharmacy, School of Medicine, The Sixth Affiliated Hospital of South China University of Technology (Nanhai District People's Hospital of Foshan), Foshan, 528200, China.
  • Zhejiang Provincial People's Hospital Bijie Hospital & the First People's Hospital of Bijie, Bijie, 551700, China.
  • Department of Pharmacy, School of Medicine, The Sixth Affiliated Hospital of South China University of Technology (Nanhai District People's Hospital of Foshan), Foshan, 528200, China. Electronic address: lywuzq@scut.edu…
  • School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 561113, China; Department of Pharmacy, School of Medicine, The Sixth Affiliated Hospital of South China University of Technology (Nanhai District P…

Zitieren

APA

Yang, K., Li, J., Zhao, X., Wu, Z., & Ye, L. (2026). Lianhua Qingwen granules biphasically regulate CYP3A4 and mediate metabolic drug interactions via LXRα-interfered dynamic rearrangement of PXR–HSP90α/RXRα/SRC-1 complex. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2026.116357

Vancouver

Yang K, Li J, Zhao X, Wu Z, Ye L. Lianhua Qingwen granules biphasically regulate CYP3A4 and mediate metabolic drug interactions via LXRα-interfered dynamic rearrangement of PXR–HSP90α/RXRα/SRC-1 complex. Food and Chemical Toxicology. 2026. doi:10.1016/j.fct.2026.116357

BibTeX
@article{Yang2026,
  author = {Yang, Kexin and Li, Jiangping and Zhao, Xinqian and Wu, Zuqiang and Ye, Linhu},
  title = {Lianhua Qingwen granules biphasically regulate CYP3A4 and mediate metabolic drug interactions via LXRα-interfered dynamic rearrangement of PXR–HSP90α/RXRα/SRC-1 complex},
  journal = {Food and Chemical Toxicology},
  year = {2026},
  doi = {10.1016/j.fct.2026.116357}
}
Kostenlos starten →